Wikipedia -WSS

Wikipedia

author：leisure time 2025-10-01 04:12:07 - browse：87

Red blood cells flow in an artery biotech — coverage from STAT — Adobe

PHILADELPHIA — An investigational drug aimed at preventing strokes significantly reduced the risk of bleeding compared with a commonly used blood thinner for stroke prevention, showing potential to be a safer alternative for patients.

Among patients with atrial fibrillation, an abnormal heart rhythm that increases the risk of stroke, abelacimab, developed by Anthos Therapeutics, cut the overall risk of bleeding by 67% compared to rivaroxaban, the blood thinner sold as Xarelto by Janssen Pharmaceuticals.

The treatment, injected monthly, also reduced the risk of major bleeding events by 74% and gastrointestinal bleeding by 93%, according to Phase 2 results presented here Sunday at the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Wegovy, Zepbound and weight loss drugs that preserve muscle

focus

WSS

Tesla CFO Zachary Kirkhorn steps down, but will remain with company through year's end

PBM reforms clear House panel

U.K. considers world's first use of meningitis vaccine to address gonorrhea

Thousands in Haiti march to demand safety from violent gangs as killings and kidnappings soar

Poor hospice wound care hurts patients and families

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

leisure time

Wikipedia

hotspot

In age of alternative facts, a scholarly course on calling out crap

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Supreme Court strikes down use of affirmative action

In key trial, Verve's treatment lowers cholesterol levels in patients

Sports medicine is finally prioritizing gender equality

Gain of function research would be limited under House proposal

Medical leaders decry Supreme Court decision on affirmative action

Democratic lawmaker calls for 'well

Supreme Court strikes down use of affirmative action

Boeing's 1st astronaut flight bumped into next year, more repairs needed

focus

'The Exorcist' director William Friedkin dead at 87

Gain of function research would be limited under House proposal

NYU radiologists take on the challenge of expensive MRI machines

David Sabatini, ex

Boeing's 1st astronaut flight bumped into next year, more repairs needed

Tesla CFO Zachary Kirkhorn steps down, but will remain with company through year's end

focus

focus

focus

focus